Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Breaks Below Two Hundred Day Moving Average Following Analyst Downgrade

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) crossed below its 200-day moving average during trading on Tuesday after Barclays downgraded the stock from an equal weight rating to an underweight rating. The stock has a 200-day moving average of $22.91 and traded as low as $22.53. Fresenius Medical Care AG & Co. KGaA shares last traded at $22.7460, with a volume of 1,396,143 shares changing hands.

A number of other equities research analysts also recently issued reports on the stock. Truist Financial reduced their price objective on shares of Fresenius Medical Care AG & Co. KGaA from $25.00 to $24.00 and set a “hold” rating on the stock in a research note on Monday, October 12th. Zacks Research cut shares of Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Weiss Ratings raised shares of Fresenius Medical Care AG & Co. KGaA from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Citigroup reaffirmed a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, July 17th. Finally, Berenberg Bank set a $24.00 price target on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, September 29th. Seven analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $23.42.

Hedge Funds Weigh In On Fresenius Medical Care AG & Co. KGaA

A number of hedge funds have recently modified their holdings of the business. Teachers Retirement System of The State of Kentucky raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 35.6% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 1,106,400 shares of the company’s stock worth $24,761,000 after acquiring an additional 290,200 shares during the last quarter. Russell Investments Group Ltd. lifted its position in Fresenius Medical Care AG & Co. KGaA by 67.3% in the 3rd quarter. Russell Investments Group Ltd. now owns 22,959 shares of the company’s stock valued at $514,000 after acquiring an additional 9,233 shares in the last quarter. Fifth Third Bancorp boosted its stake in Fresenius Medical Care AG & Co. KGaA by 39.6% during the 3rd quarter. Fifth Third Bancorp now owns 25,653 shares of the company’s stock valued at $574,000 after purchasing an additional 7,278 shares during the last quarter. Ritholtz Wealth Management boosted its stake in Fresenius Medical Care AG & Co. KGaA by 5.2% during the 3rd quarter. Ritholtz Wealth Management now owns 135,135 shares of the company’s stock valued at $3,024,000 after purchasing an additional 6,732 shares during the last quarter. Finally, Commonwealth Equity Services LLC acquired a new position in Fresenius Medical Care AG & Co. KGaA during the 3rd quarter valued at about $278,000. Institutional investors and hedge funds own 8.37% of the company’s stock.

Fresenius Medical Care AG & Co. KGaA Price Performance

The company has a current ratio of 0.99, a quick ratio of 0.69 and a debt-to-equity ratio of 0.37. The business has a fifty day simple moving average of $22.33 and a 200 day simple moving average of $22.91. The stock has a market capitalization of $12.11 billion, a P/E ratio of 13.15, a price-to-earnings-growth ratio of 5.40 and a beta of 0.78.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last announced its earnings results on Tuesday, November 3rd. The company reported $0.64 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.01). The firm had revenue of $5.59 billion during the quarter, compared to analysts’ expectations of $5.52 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.23% and a return on equity of 9.08%. On average, analysts expect that Fresenius Medical Care AG & Co. KGaA will post 2.23 earnings per share for the current year.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co. KGaA is a healthcare company focused on treating people with chronic kidney failure. It provides dialysis care through a global network of treatment centers and supports patients who receive care in clinics or at home. The company also develops and supplies products used in dialysis, including dialysis machines, dialyzers, and related medical equipment and materials. Its services include clinical care and support for healthcare providers involved in kidney treatment.